scholarly article | Q13442814 |
P50 | author | Ralph Weissleder | Q7288259 |
Xandra O. Breakefield | Q63607934 | ||
Randa Kasmieh | Q125261420 | ||
P2093 | author name string | Khalid Shah | |
Jose Luiz Figueiredo | |||
Shawn Hingtgen | |||
Alberto Martinez-Serrano | |||
Elisa Garcia-Garcia | |||
P2860 | cites work | Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome | Q28235047 |
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | Q29547503 | ||
Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors | Q29547596 | ||
Mammalian neural stem cells | Q29547657 | ||
Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos | Q30476162 | ||
In vivo magnetic resonance tracking of magnetically labeled cells after transplantation | Q30712538 | ||
Novel multiwavelength microscopic scanner for mouse imaging | Q33228643 | ||
Development of a self-inactivating lentivirus vector. | Q33784841 | ||
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. | Q33896810 | ||
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. | Q34287902 | ||
Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. | Q34309273 | ||
Human neural stem and progenitor cells: in vitro and in vivo properties, and potential for gene therapy and cell replacement in the CNS. | Q34729483 | ||
Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
In vivo imaging of leukocyte trafficking in blood vessels and tissues | Q35832004 | ||
Stem cell therapy for human neurodegenerative disorders-how to make it work | Q35844778 | ||
Fluorescence molecular imaging of small animal tumor models. | Q35881618 | ||
Regulatory T cells, tumour immunity and immunotherapy | Q36430144 | ||
Reversal of tumor-mediated immunosuppression | Q36718968 | ||
Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors | Q37570436 | ||
Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells. | Q40295178 | ||
SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion. | Q40406965 | ||
Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas. | Q40452452 | ||
Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. | Q40476541 | ||
Optimized large-scale production of high titer lentivirus vector pseudotypes | Q40492522 | ||
Gene marking of human neural stem/precursor cells using green fluorescent proteins | Q40499382 | ||
Long-term molecular and cellular stability of human neural stem cell lines. | Q40578181 | ||
Genetically perpetuated human neural stem cells engraft and differentiate into the adult mammalian brain | Q40758370 | ||
Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. | Q40899057 | ||
Multipotent neural progenitor or stem-like cells may be uniquely suited for therapy for some neurodegenerative conditions | Q41207881 | ||
Immortalized neural progenitor cells for CNS gene transfer and repair. | Q41639955 | ||
Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis | Q42944903 | ||
Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo | Q44611172 | ||
The integrated genome of murine leukemia virus | Q45889290 | ||
Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand | Q46324484 | ||
Loss of gene expression in lentivirus- and retrovirus-transduced neural progenitor cells is correlated to migration and differentiation in the adult spinal cord | Q46514786 | ||
In vivo tracking of neural progenitor cell migration to glioblastomas | Q48209565 | ||
In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord | Q48966032 | ||
In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. | Q50756106 | ||
Transplantation of human neural stem cells for spinal cord injury in primates. | Q51527726 | ||
Vascular microenvironment in gliomas | Q57188093 | ||
Host immune response in renal cell cancer: Interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes | Q57209343 | ||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | neural stem cell | Q2944097 |
P304 | page(s) | 4406-4413 | |
P577 | publication date | 2008-04-01 | |
P1433 | published in | Journal of Neuroscience | Q1709864 |
P1476 | title | Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model | |
P478 | volume | 28 |
Q34341900 | A first-generation multi-functional cytokine for simultaneous optical tracking and tumor therapy |
Q39744489 | A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. |
Q34979703 | A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma |
Q35653261 | Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas |
Q37140126 | Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy |
Q33753135 | Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors |
Q39012723 | Chemotactic responses of neural stem cells to SDF-1α correlate closely with their differentiation status |
Q38960128 | Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors |
Q54592798 | Differentiation of neural stem cells influences their chemotactic responses to vascular endothelial growth factor. |
Q39188017 | Dynamics of focal adhesions and reorganization of F-actin in VEGF-stimulated NSCs under varying differentiation states. |
Q30843565 | Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma |
Q36695971 | Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas |
Q34444939 | Engineering toxin-resistant therapeutic stem cells to treat brain tumors |
Q94660275 | Generation and Profiling of Tumor-Homing Induced Neural Stem Cells from the Skin of Cancer Patients |
Q47405412 | Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell |
Q39725116 | Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors. |
Q37352907 | In Vivo Cellular Imaging for Translational Medical Research |
Q39940650 | In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma. |
Q37791278 | In vivo imaging in cancer |
Q33519142 | In vivo neural stem cell imaging: current modalities and future directions. |
Q39397148 | Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells. |
Q38515294 | Lentiviral vectors as tools to understand central nervous system biology in mammalian model organisms. |
Q59131876 | MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma |
Q36092724 | Mesenchymal stem cells engineered for cancer therapy |
Q37938466 | Migration and fate of therapeutic stem cells in different brain disease models. |
Q36512525 | Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors |
Q39012877 | Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384. |
Q33704489 | Neural stem cell therapy for cancer |
Q37096766 | Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo |
Q38353261 | Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke. |
Q38974708 | PET imaging of glioblastoma multiforme EGFR expression for therapeutic decision guidance. |
Q36129857 | Probe-Based Confocal Laser Endomicroscopy for Imaging TRAIL-Expressing Mesenchymal Stem Cells to Monitor Colon Xenograft Tumors In Vivo |
Q34092169 | Promoted Growth of Brain Tumor by the Transplantation of Neural Stem/Progenitor Cells Facilitated by CXCL12. |
Q36913828 | Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors |
Q36543537 | Real-time multi-modality imaging of glioblastoma tumor resection and recurrence. |
Q33622514 | Stem cell transplantation in brain tumors: a new field for molecular imaging? |
Q38855638 | Stem cell-based therapies for tumors in the brain: are we there yet? |
Q40122051 | Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas |
Q42218017 | Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy. |
Q35974503 | Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells |
Q35153149 | Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors |
Q37356520 | Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide |
Q34986247 | The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas |
Q49936618 | Therapeutic Neural Stem Cells Engineered During Different Stages of Reprogramming Reveal Varying Therapeutic Efficacies |
Q39198277 | Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors |
Q40178043 | Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus. |
Q34263640 | Tracking stem cells for cellular therapy in stroke |
Q38950411 | Translation of the ecological trap concept to glioma therapy: the cancer cell trap concept |
Q48329121 | Tumor-homing cytotoxic human induced neural stem cells for cancer therapy. |
Q38730790 | Use of genetically engineered stem cells for glioma therapy |
Q38737932 | Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology |
Q41920847 | microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis |